Takara Bio Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TKBIF research report →
Price Chart
About the company
Takara Bio Inc. , a subsidiary of Takara Holdings Inc. , is a Japan-based biotechnology firm established in Kusatsu in 2002.
- CEO
- Tsuyoshi Miyamura
- IPO
- 2020
- Employees
- 1,838
- HQ
- Kusatsu, SH, JP
Get TickerSpark's AI analysis on TKBIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $879.03M
- P/E
- -14.35
- Fwd P/E
- 131.89
- PEG
- 0.03
- P/S
- 3.42
- P/B
- 1.33
- EV/EBITDA
- -41.34
- Div Yield
- 0.00%
- Gross Margin
- 50.25%
- Op Margin
- -11.63%
- Net Margin
- -23.81%
- ROE
- -9.22%
- ROIC
- -3.72%
Latest fiscal year · YoY change
- Revenue
- $253.92M-18.0%
- Gross Profit
- $127.60M-28.8%
- Op Income
- $-29,525,024
- Net Income
- $-60,448,204-944.5%
- EPS
- $-0.50-940.3%
- OCF Growth
- -43.9%
- FCF Growth
- -85.8%
- 52W High
- $23.20
- 52W Low
- $5.00
- 50D MA
- $7.30
- 200D MA
- $13.27
- Beta
- 0.43
- RSI (14)
- 45
- Avg Volume
- 18
No earnings-call transcripts are available for TKBIF yet.
- Free Float
- 37.3%
- Shares Outstanding
- 120.42M
- Float Shares
- 44.89M
Our TKBIF coverage
Recent articles, reports, and earnings notes.
No research on TKBIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TKBIF report →